The Trump administration’s rescheduling order moved FDA-approved marijuana drug products and certain state-regulated medical marijuana products from Schedule I to Schedule III. But for Americans who grow their own at home, the most basic question, did anything actually change for me?, depends entirely on which cannabis attorney you ask. We asked four. They disagree. On… Keep Reading
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law. If you’re trying to understand what that actually means — for dispensaries, patients, cannabis businesses and federal policy — this is the explainer. For… Keep Reading
As we all know, cannabis is a plant. But many cannabis products aren’t. That might sound obvious, but if you walk into most dispensaries today, you might start to wonder if the industry remembers that. Because the reality is that most cannabis consumers today are not actually getting products that resemble the whole plant. What… Keep Reading
